Nicholas Hoffman & Company’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.34M Buy
11,033
+67
+0.6% +$8.11K 0.03% 107
2025
Q1
$1.22M Buy
10,966
+1,008
+10% +$112K 0.05% 109
2024
Q4
$969K Sell
9,958
-31
-0.3% -$3.02K 0.04% 125
2024
Q3
$1.15M Buy
9,989
+108
+1% +$12.4K 0.05% 114
2024
Q2
$1.05M Sell
9,881
-40
-0.4% -$4.26K 0.05% 116
2024
Q1
$960K Buy
9,921
+64
+0.6% +$6.19K 0.05% 126
2023
Q4
$995K Hold
9,857
0.06% 119
2023
Q3
$1M Sell
9,857
-70
-0.7% -$7.13K 0.07% 111
2023
Q2
$1M Buy
9,927
+276
+3% +$27.9K 0.04% 115
2023
Q1
$888K Hold
9,651
0.08% 123
2022
Q4
$876K Buy
9,651
+10
+0.1% +$907 0.09% 121
2022
Q3
$733K Buy
9,641
+260
+3% +$19.8K 0.03% 128
2022
Q2
$793K Sell
9,381
-211
-2% -$17.8K 0.04% 123
2022
Q1
$842K Buy
9,592
+90
+0.9% +$7.9K 0.03% 124
2021
Q4
$831K Buy
9,502
+17
+0.2% +$1.49K 0.03% 126
2021
Q3
$776K Sell
9,485
-824
-8% -$67.4K 0.14% 126
2021
Q2
$941K Buy
10,309
+53
+0.5% +$4.84K 0.17% 111
2021
Q1
$877K Buy
10,256
+1,427
+16% +$122K 0.18% 110
2020
Q4
$834K Buy
8,829
+27
+0.3% +$2.55K 0.19% 98
2020
Q3
$765K Buy
8,802
+739
+9% +$64.2K 0.2% 96
2020
Q2
$704K Buy
8,063
+460
+6% +$40.2K 0.2% 97
2020
Q1
$627K Buy
7,603
+384
+5% +$31.7K 0.21% 99
2019
Q4
$684K Hold
7,219
0.19% 112
2019
Q3
$627K Hold
7,219
0.19% 113
2019
Q2
$659K Sell
7,219
-1,357
-16% -$124K 0.2% 107
2019
Q1
$739K Sell
8,576
-1,756
-17% -$151K 0.24% 101
2018
Q4
$794K Hold
10,332
0.27% 83
2018
Q3
$798K Sell
10,332
-340
-3% -$26.3K 0.27% 86
2018
Q2
$722K Buy
10,672
+8
+0.1% +$541 0.27% 89
2018
Q1
$773K Sell
10,664
-129
-1% -$9.35K 0.3% 85
2017
Q4
$812K Sell
10,793
-701
-6% -$52.7K 0.32% 79
2017
Q3
$884K Buy
11,494
+658
+6% +$50.6K 0.37% 73
2017
Q2
$810K Buy
10,836
+705
+7% +$52.7K 0.37% 71
2017
Q1
$674K Sell
10,131
-191
-2% -$12.7K 0.32% 77
2016
Q4
$674K Buy
10,322
+24
+0.2% +$1.57K 0.34% 75
2016
Q3
$729K Buy
10,298
+120
+1% +$8.5K 0.4% 66
2016
Q2
$752K Buy
+10,178
New +$752K 0.43% 62